+1-646-568-9980, +44-203-287-6050
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
obesity treatment market

Global Obesity Treatment Market, By Procedure Type (Gastric Bypass, Gastric Banding, Non-Invasive Surgery, Sleeve Gastrectomy); By Products Type (Gastric Bands, Gastric Balloons, Stapling Devices, Gastric Electrical Stimulators); By Drug Type (Malabsorption & Satiety Drugs, Combination Drugs, Appetite Suppressants)]; and Geography - Trend, Analysis and Forecast till 2025

Published: Aug 2018
Pages: 0
Format: PDF
Report ID: PM1367
License and Pricing
Buy Now Inquire Before Buying

Report Summary

The global obesity treatment market is expected to gain traction owing to the factors such as rising number of obese population, and increasing number of bariatric surgeries for treating obesity.

Obesity is termed as medical condition with excess of body fat is accumulated that can be harmful to one’s health. Obesity is completely different from being overweight. Basically, obesity is mainly caused due to the imbalance between calories-in and calories-out of each person. Moreover, the factors like defective genetic makeup, overeating, eating high fat food, and lack of physical activities also lead to obesity. In some cases, obesity is caused due to endocrine disorders, medications, or mental disorders. Obesity increases the risk of diabetes, heart disease, stroke, and also influences certain medical conditions like Cushing syndrome, depression, Prader-Willi syndrome, and polycystic ovarian disorders. There is a continuous increase in the obesity rate in the adults and children as well. According to National Health and Nutrition Examination Survey (NHANES), in 2014 reported more than 2 in 3 adults are suffering for obesity, and 1 in 6 children and adolescent age 2 to 19 considered to have obesity.

For the treatment of obesity, surgery is the most preferred method of treatment known as bariatric surgery, gastric bypass surgery, adjustable gastric banding, Roux-en-Y gastric bypass, and gastric sleeve. Moreover, WHO stated, in 2016 above 650 million are obese, and the number of obese population is supposed to grow. Hence, this factor is one of the major driving force in the obesity treatment market.

Improved technology, increasing research and development for innovation of major combined drug, and rising demand for minimal invasive treatment as an alternative treatment are factors to support the growth of global obesity treatment market.

The global obesity treatment market is primarily driven by growing rate of obesity across the globe, and rising number of obese population in the developing economies. Moreover, increasing awareness for about minimal invasive surgeries and rising number of bariatric surgeries to augment the growth of obesity treatment market in the near future.

Moreover, shifting preference towards sedentary lifestyle, which in turn has reduced the physical activity, and changing food habits leads to weight gain. Also, growing consumption of fast food and read-to-eat food, and improving healthcare infrastructure in the developing economies will surge the obesity treatment market during the forecast period.

Global Obesity Treatment Market Taxonomy

The global obesity treatment market is segmented on the basis of procedure type, product type, drug type, and geography.

On the basis of procedure type, market is segmented into:

  • Gastric Bypass
  • Gastric Banding
  • Non-Invasive Surgery
  • Sleeve Gastrectomy

On the basis of product type, market is segmented into:

  • Gastric Band
  • Gastric Balloon
  • Stapling Devices
  • Gastric Electrical Stimulators

On the basis of drug type, market is segmented into:

  • Malabsorption & Satiety Drugs
  • Combination Drugs
  • Appetite Suppressants.

Obesity treatment market, by procedure type is majorly categorized into Gas Bypass, Gastric Banding, Non-Invasive Surgery, and Sleeve Gastrectomy. Increasing awareness and number of the non-invasive surgeries expected to support the growth of non-invasive surgery market in the obesity treatment market.

The global non-invasive surgery market is primarily driven by increasing acceptance and  adoption of bariatric surgeries across the globe, along with rising awareness for its use as an effective treatment of obesity. According to American Society for Metabolic and Bariatric Surgery, recorded approximately 216, 000 surgeries which is validts the non-invasive surgery market growth during the forecast period.  

Geographically, the global obesity treatment market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increased expenditure on R&D for developing new and effective treatments on obesity and increasing obese population to lead the obesity treatment market in North America.

North America is expected to dominate the obesity treatment market over the forecast period. This region holds major share owing to the increasing obese population influenced by the changed lifestyles in this region and the rising expenditure on R&D and healthcare infrastructure.

However, Asia Pacific market is expected to grow at a higher rate during the forecast period. Increasing number of patients with obesity, increased awareness for the of minimal invasive surgeries, and developing healthcare infrastructure of the developing countries like China, Japan, and India are the major factors anticipated to govern the growth in global obesity treatment market during upcoming years.

Key players in the global obesity treatment market are:

  • Hoffmann-La Roche Ltd.
  • Novo Nordisk A/S
  • VIVUS Inc.
  • Allergan plc.
  • Arena Pharmaceuticals
  • Medtronic plc.
  • Ethicon Inc. (Johnson & Johnson)
  • Entero Medics
  • Cousin Biotech
  • Intuitive Surgical Inc.
  • Mediflex Surgical Products
  • Apollo Endosurgery, Inc.

 

Key Take-Away